MedPath

The Impact of PM+For Moms Intervention on Improving Mother's Mental Health in Zambia (PM+FM)

Not Applicable
Completed
Conditions
Trauma, Psychological
Depressive Symptoms
Anxiety
Interventions
Behavioral: Problem Management + For Moms
Registration Number
NCT05627206
Lead Sponsor
Swiss Tropical & Public Health Institute
Brief Summary

CMHD are particularly prevalent among women, posing a major threat to their own and their children's wellbeing.

Despite the high prevalence of CMHD and the existence of effective treatments, interventions supporting women living in low-resourced settings remain limited.

This study builds on a parent study (Zamcharts NCT03991182), which identified a high prevalence of women with anxiety and/or depression. We propose to design, test, and validate a community-based intervention nested within the public primary health system in Zambia, to identify and treat women with mild-to-severe CMHDs.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
270
Inclusion Criteria
  • Women participating in ZamCharts parent study
  • SRQ-20 >7 (clinically significant symptoms of depression or/anxiety),
  • not planning to move within the next 6 months,
  • with capacity to consent
  • not receiving current mental health care.
Exclusion Criteria
  • Women with active suicidal ideation (determined by Paykel=4 OR 5),
  • severe substance use (ACOK-SUD >4),
  • mania or psychotic symptoms

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
InterventionProblem Management + For Moms-
Primary Outcome Measures
NameTimeMethod
Change in Mental health symptoms. SRQ-20Change between Baseline (at enrollment) and 6 months after enrollment

20 items measuring risk of common mental health problem.

Feasibility of the studyAssessed 4 months after enrollment

% of 1 or more sessions completed. Qualitative feedback from participants and providers.

AcceptabilityAssessed 4 months after enrollment

% of participants completing more than 6 sessions. Qualitative feedback from participants and providers.

Secondary Outcome Measures
NameTimeMethod
FunctionalityUsed for the pre-post treatment analysis. Change between Baseline (at enrollment) and 4 months after enrollment

WHO-DAS2

Change in Anxiety and Depression symptoms.Used for the pre-post treatment analysis. Change between Baseline (at enrollment) and 4 months after enrollment

HSCL-25. 10 questions anxiety, 15 depression; (α = 0.90).

World Bank's Toolkit and InventoryUsed for the pre-post treatment analysis. Change between Baseline (at enrollment) and 4 months after enrollment

Selected measures from the World Bank Toolkit to address mother-child interactions and child early development.

Change in Mental health symptoms. PSYCHLOPSUsed for the pre-post treatment analysis. Change between Baseline (at enrollment) and 4 months after enrollment

Psychological Outcome Profiles (5 items)

Trial Locations

Locations (1)

Innovatations for Poverty Action

🇿🇲

Lusaka, Zambia

© Copyright 2025. All Rights Reserved by MedPath